status: 200
content-location: http://rest.kegg.jp/get/map00450
server: Apache
date: Wed, 15 Oct 2014 15:07:45 GMT
content-type: text/plain

ENTRY       map00450                    Pathway
NAME        Selenocompound metabolism
CLASS       Metabolism; Metabolism of other amino acids
PATHWAY_MAP map00450  Selenocompound metabolism
DISEASE     H00183  Homocystinuria
            H00184  Hypermethioninemia
            H00761  SEMD, Pakistani type
            H01285  Methylcobalamin deficiency type G (cblG)
REFERENCE   PMID:21190829
  AUTHORS   Hoefig CS, Renko K, Kohrle J, Birringer M, Schomburg L
  TITLE     Comparison of different selenocompounds with respect to nutritional value vs. toxicity using liver cells in culture.
  JOURNAL   J Nutr Biochem (2010)
REFERENCE   PMID:19051051
  AUTHORS   McKenzie MJ, Hunter DA, Pathirana R, Watson LM, Joyce NI, Matich AJ, Rowan DD, Brummell DA
  TITLE     Accumulation of an organic anticancer selenium compound in a transgenic Solanaceous species shows wider applicability of the selenocysteine methyltransferase transgene from selenium hyperaccumulators.
  JOURNAL   Transgenic Res 18:407-24 (2009)
REFERENCE   PMID:20383543
  AUTHORS   Pinto JT, Lee JI, Sinha R, MacEwan ME, Cooper AJ
  TITLE     Chemopreventive mechanisms of alpha-keto acid metabolites of naturally occurring  organoselenium compounds.
  JOURNAL   Amino Acids 41:29-41 (2011)
REFERENCE   PMID:17451884
  AUTHORS   Suzuki KT, Kurasaki K, Suzuki N
  TITLE     Selenocysteine beta-lyase and methylselenol demethylase in the metabolism of Se-methylated selenocompounds into selenide.
  JOURNAL   Biochim Biophys Acta 1770:1053-61 (2007)
REFERENCE   PMID:11782468
  AUTHORS   Gromer S, Gross JH
  TITLE     Methylseleninate is a substrate rather than an inhibitor of mammalian thioredoxin reductase. Implications for the antitumor effects of selenium.
  JOURNAL   J Biol Chem 277:9701-6 (2002)
KO_PATHWAY  ko00450
///
